BNN-27

BNN-27 is a synthetic neurosteroid, and a derivative of DHEA. It has been found to promote the survival and regeneration of neurons, and to increase the number of dendritic spines, in animal studies. BNN-27 has been found to bind to and activate the sigma-1 receptor, and this action is thought to be involved in its neuroprotective effects. It has also been found to inhibit the nuclear factor kappa B (NF-κB) pathway, which is involved in inflammation and cell death, and this action may also be involved in its neuroprotective effects.

Pharmacology

Pharmacodynamics

BNN-27 is a synthetic neurosteroid and a derivative of DHEA. It has been found to bind to and activate the sigma-1 receptor, and this action is thought to be involved in its neuroprotective effects. BNN-27 has also been found to inhibit the NF-κB pathway, which is involved in inflammation and cell death, and this action may also be involved in its neuroprotective effects.

Research

BNN-27 has been studied in animal models of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. In these studies, it has been found to promote the survival and regeneration of neurons, and to increase the number of dendritic spines. BNN-27 has also been found to have anti-inflammatory effects, which may contribute to its neuroprotective effects.

See also

• Neurosteroid
• Sigma-1 receptor
• DHEA
• NF-κB

BNN-27 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski